Clinical Trial Update: Clinical Importance of Treating Iron Overload in Sickle Cell Disease [Phase 3]

View source ↗

Summary

This is a Phase 3 trial update about the clinical importance of treating iron overload in sickle cell disease. The study status is TERMINATED, and results were …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sickle Cell Disease
• Transfusion Hemosiderosis

Snippet

Sponsor: Children's Hospital Los Angeles | Conditions: Anemia, Sickle Cell, Transfusion Hemosiderosis | Phase 3 | Status: TERMINATED | Results posted: 2017-02-08